Antibodies
15 October 2012
Amgen Presents Several Sub-Analyses At ASBMR From The Ongoing Open-Label Extension Study Of The Pivotal Phase 3 Prolia Fracture Trial12 October 2012
FAB’ENTECH launches a Phase I clinical trial in Singapore for its new product against H5N1 Avian Influenza11 October 2012
TYSABRI (natalizumab) Data at ECTRIMS Reaffirm Positive Effects of Treatment for People with Relapsing Forms of MS9 October 2012
Seattle Genetics Achieves Milestones as Genentech Advances Two Antibody-Drug Conjugates (ADCs) into Phase II Development8 October 2012
Journal of Clinical Oncology publishes Phase III results of ZALTRAP (aflibercept) VELOUR study8 October 2012
Merus announces the full validation of its MeMo(R) transgenic mouse for common light chain human antibodies4 October 2012
OncoMed Pharmaceuticals Advances Two Notch Pathway Product Candidates in Clinical Development3 October 2012
Lpath Begins iSONEP Dosing in Nexus Phase 2 Study3 October 2012
MERRIMACK PHARMACEUTICALS’ THERAPIES SHOW PROMISE IN CERTAIN ADVANCED BREAST, GASTRIC AND GYNECOLOGIC CANCERS1 October 2012
Roche’s trastuzumab emtansine (T-DM1) significantly extended survival in people with aggressive form of breast cancer28 September 2012
Progenics Pharmaceuticals Initiates Phase 2 Clinical Trial of PSMA ADC in Prostate Cancer Patients28 September 2012
New Data Demonstrate STELARA (ustekinumab) is Effective, Well-Tolerated and Improved Quality of Life in Patients with Moderate to Severe Plaque Psoriasis28 September 2012
Lonza and Intellect Neurosciences Announces Intellect’s Intention to Award Production of Its Antibody Drug Conjugate, CONJUMAB-A to Lonza28 September 2012
XOMA Announces Servier Has Initiated Phase 3 Gevokizumab Trial in Patients With Behcet’s Uveitis27 September 2012
CSL drug candidate in diabetes research breakthroughNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports